<DOC>
	<DOCNO>NCT01555255</DOCNO>
	<brief_summary>This study seek determine whether screen pregnant woman malaria malaria rapid diagnostic test ( RDTs ) may detect placental infection predict risk poor birth outcome due malaria area vary malaria transmission Africa .</brief_summary>
	<brief_title>Malaria Rapid Diagnostic Tests ( RDTs ) Pregnancy : Detection Placental Malaria</brief_title>
	<detailed_description>Malaria prevention measure pregnant woman critical available , effectiveness intermittent preventive treatment ( IPTp ) sulfadoxine-pyrimethamine , cornerstone prevention effort , decline increase parasite resistance . New drug IPTp consider , disadvantage presumptive use remain efficacious antimalarial . An alternative approach may involve screen diagnostic test well target efficacious antimalarial treatment asymptomatic woman laboratory evidence malaria infection . Light microscopy peripheral maternal blood miss large proportion case , PCR unavailable routine health care setting . Preliminary evidence suggest detection parasite antigen peripheral blood may provide accurate indicator clinically significant infection predict pregnancy outcome . Therefore , screen RDTs may offer accurate practical way identify pregnant woman benefit targeted therapy placental malaria infection . Antigen detection threshold vary widely among RDTs , distribution target antigens peripheral blood circulation expect differ ; therefore , potential value RDTs population best establish evaluate detection placental parasitemia highly-characterized RDTs , enable result extrapolated product program . The study describe propose address question .</detailed_description>
	<mesh_term>Malaria</mesh_term>
	<criteria>Specific participant selection criterion include : 1 . Presenting care quicken onset labor ( i.e . second third trimester pregnancy ) 2 . Age 16 year 44 year , inclusive 3 . Willingness ability follow study visit activity duration pregnancy delivery 4 . Absence history serious adverse reaction sulfa drug 5 . Absence history serious adverse reaction artemisininbased drug ( depend national policy treatment malaria pregnancy ) 6 . Absence HIV infection ( guideline malaria prevention pregnancy HIVinfected woman differ HIVnegative woman , order avoid confound pregnancy outcomes HIVrelated complication treatment early evaluation ) 7 . Absence history current obstetrical complication ( e.g . preeclampsia , eclampsia , hypertension pregnancy , postpartum hemorrhage , evidence multiple gestation ) 8 . Absence chronic disease ( e.g . diabetes mellitus , sickle cell disease ) 9 . Absence evidence severe acute disease require inpatient management referral 10 . Provision write informed consent 11 . Enrollment Hb â‰¥7 g/dL</criteria>
	<gender>Female</gender>
	<minimum_age>16 Years</minimum_age>
	<maximum_age>44 Years</maximum_age>
	<verification_date>October 2012</verification_date>
	<keyword>malaria</keyword>
	<keyword>pregnancy</keyword>
	<keyword>placental malaria</keyword>
	<keyword>malaria pregnancy</keyword>
	<keyword>birth weight</keyword>
	<keyword>anemia</keyword>
</DOC>